In Brief
As part of the Human Functional Genomics Project, examination of millions of human genetic variants demonstrates that host genetics plays a significant role in inter-individual variability of cytokine production in response to different types of microbial stimuli.
INTRODUCTION
The Human Functional Genomics Project (HFGP) is an initiative that aims to identify the factors responsible for the variability of immune responses in health and disease (http://www. humanfunctionalgenomics.org). Within the HFGP, the 500-Human Functional Genomics (500FG) cohort focuses on gaining a broader understanding of the variability in human cytokine responses. In a first study reported in this issue of Cell, we investigated the role of environmental and non-genetic host factors for cytokine responses (ter Horst et al., 2016) . In the present study, we investigate the role of genetic variation for individuals human cytokine responses, while a third complementary study assessed the impact of microbiome factors .
Many targeted candidate gene studies have demonstrated the impact of specific genetic variants on immune responses, while a recent study that assessed the genetics of lipopolysaccharide (LPS)-induced cytokine responses by dendritic cells identified several candidate genes (Lee et al., 2014) . Furthermore, genome-wide genetic studies have found genetic variants that impact transcript abundance for immune genes (so-called eQTLs [expression quantitative trait loci]) (Kumar et al., 2014a; Fairfax et al., 2014; Lee et al., 2014) , while genome-wide association studies (GWASs) have identified hundreds of genetic variants predisposing to the susceptibility to immune-mediated diseases and/or their severity (Welter et al., 2014) . However, there have been no comprehensive genome-wide association studies to investigate variation in cytokine production in humans so far. As a proof of concept, we assessed the genetics of three monocyte-derived cytokines (tumor necrosis factor a [TNF-a], interleukin [IL]-1b, and IL-6) after stimulation with a few microbial stimuli: we identified four genome-wide loci that influence cytokine release (Li et al., 2016) . This clearly demonstrated the importance of genetic variation for cytokine production in humans, and we decided to pursue a more comprehensive approach to reveal the most important genetic factors that influence cytokine responses.
Here, we describe the stimulation of three different cellular systems (whole blood, peripheral blood mononuclear cells [PBMCs] , and macrophages) with a broad panel of bacterial, fungal, viral, and non-microbial stimuli to induce cytokine production, which was analyzed with approximately 8.0 million genetic variants (SNPs). The discovery was performed in the 500FG cohort, and validation was performed in the 200FG cohort. We were able to validate 17 new genome-wide significant loci that represent cytokine QTLs (cQTLs), and we describe new pathways for the modulation of cytokine responses in humans.
RESULTS

Overview of Cytokine Response Architecture
We assessed cytokine production capacity in the 500FG discovery cohort in three cellular systems: whole-blood stimulations, PBMC stimulations, and stimulation of monocyte-derived macrophages. We used a comprehensive range of seven bacterial, three fungal, one viral, four Toll-like receptor (TLR) ligands, and two non-microbial metabolic stimuli to assess three monocytederived and three lymphocyte-derived cytokines (see Figure 1 for overview).
Significant increases in the levels of all cytokines were observed in all stimulation systems compared to steady-state levels (see also the related paper by Schirmer et al., 2016 , for the main bacterial and fungal stimuli, as well as Figure S1 for a full description of all stimuli). Cytokines IL-6 and TNF-a from whole blood and PBMCs showed higher inter-individual variation than production by macrophages ( Figure S2 ), suggesting that the in vitro differentiation of macrophages is a process that partly overrides individual variation. In general, IL-6 showed a much stronger inter-individual variation than any other cytokines (p < 0.001), suggesting a much stronger impact of cell types and/or genetic variation on IL-6 production than other cytokines. These results were consistent with those we obtained from the 200FG cohort (data not shown).
Unsupervised clustering of the cytokine responses showed a clear distinction between stimulations with bacteria, fungi, or We collected blood samples from 500 healthy individuals in the 500FG cohort and isolated their DNA. This was hybridized on the HumanCoreExome SNP Chip to provide genotype information on approximately 8 million SNPs. The blood was also used to perform a series of stimulation experiments with major human pathogens and to profile the cytokines released in the serum (see STAR Methods) . See also Figures S1 and S2. viruses (Figure 2A) . Correlations between the productions of various cytokines were found mainly for stimulation with a certain microbe rather than between cytokine productions induced by different microbes, which suggests that immune responses are organized to respond to a specific pathogen rather than through a specific immune pathway. The clustering also revealed a poor correlation between monocyte-derived-and T-helper-derived cytokine responses ( Figure 2A ). This is surprising, as the differentiation of naive T cells into Th1-or Th17-effector lymphocytes is controlled by monocyte-derived cytokines. However, this conclusion is also supported by our clustering analyses of whole-blood stimulations ( Figure 2B ). An exception to these patterns was the fungal Cryptococcus-induced cytokine responses, in which the distinction between monocyte-derived-and T cellderived cytokines was weak. In addition, the Cryptococcusinduced cytokines were more similar to cytokine responses induced by influenza virus than to other fungi ( Figure 2A) .
To assess whether cell-based factors are the only factor determining variation in cytokine responses, or whether plasmaderived factors can qualitatively modulate the responses, we correlated specific responses in purified PBMCs versus wholeblood stimulations ( Figure 2B ). Unsupervised clustering demonstrated stronger correlations of responses in the two stimulation systems, but we also found positive correlations between them ( Figure 2B ). These findings suggest that, although intrinsic factors in the mononuclear cells mainly determine the cytokine response, additional variation in cytokine production may also be induced by other whole-blood components, such as neutrophils or plasma factors.
Contribution of Genetic Variation to How Cytokines Respond to Pathogens
We observed that cytokines show higher inter-individual variation upon stimulation ( Figure S2 ). Since a difference in cell-count proportions can be an important factor influencing the amount of cytokines produced, we tested whether cell-count differences determine inter-individual variation in cytokine levels. For this, we obtained immune-cell-count data measured by fluorescence-activated cell sorting (FACS) for total lymphocytes, T cells, B cells, monocytes, and natural killer (NK) cells from all 500FG individuals (Aguirre-Gamboa et al., 2016) . We observed weak correlations between cell counts and cytokine levels ( Figure S3A ), suggesting a minor effect of cell-count differences on cytokine production capacity. We then estimated the proportion of cytokine variance explained by genome-wide SNPs for all cytokine measurements before and after correcting Clustering was performed using Spearman's correlation as the measure of similarity. Red indicates a strong positive correlation, whereas blue indicates a strong negative correlation. Cluster 1 depicts the positive correlation between monocyte-induced cytokines (IL-6, IL-1b, and TNF-a) on stimulation of PBMCs for 24 hr. Cluster 2 depicts the positive correlation among cytokines derived from T-helper cells (IL-17, IL-22, and IFN-g) on stimulation of PBMCs for 7 days. Cluster 3 depicts the strong correlation between influenza-and Cryptococcus-induced cytokines for both T cell-and monocyte-derived cytokines. (B) The results from unsupervised hierarchical clustering of the cytokine responses in blood were compared with responses in PBMCs. The stimulation-cytokine pairs that were available for both cell systems were chosen to perform unsupervised hierarchical clustering. Four different clusters indicate the pathogen-specific clustering of cytokines. WB, whole blood.
for age, gender, and cell counts ( Figure 3 ; Figure S3B ; Table S1 ) using the GREML method (Yang et al., 2010) .
In total, for around 70% of all the cytokine responses in PBMCs, the genetic influence was considerably larger than previously reported (>25% of explained variance) (Brodin et al., 2015) . We found similar results when we estimated heritability without correcting age, gender, and cell counts (Table S1 ). In general, we found a higher explained variance for monocytederived cytokines from genetic factors (>50% of explained variance especially for IL-6 and IL1-b) than for T cell-derived cytokines (Figure 3 ). Finding the strongest inter-individual variation in IL-6 levels upon stimulation, in addition to the highest heritability for IL-6 levels, indicates that there may be many genome-wide significant QTLs for IL-6 in the context of infectious pressure. In T cell-derived cytokines, we found a higher explained variance for IL-17 from genetic factors. Although it may be expected that the cytokine production capacity is affected by genetic factors, we observed that the estimated explained variance due to genetic factors differed for the stimulation by the various microorganisms and for the individual cytokines studied. This finding indicates there are genetic variations that may be strongly regulating the cytokine production in response to certain pathogens.
Identifying Genome-wide Genetic Variations Affecting Cytokine Production in Response to Pathogens
To identify the most significant genetic loci that determine cytokine levels upon stimulation, we mapped cQTLs using genomewide SNP genotypes. After correcting for age, gender, and cell counts, we identified 18 genome-wide (p < 5 3 10 À8 ) significant lead SNPs in 17 independent loci ( Figures 4A and 4B ). These include seven independent QTLs for IL-6, three independent QTLs for IL-1b, and three independent QTL for TNF-a levels (Table 1) . Of the 17 loci, all but one were identified for cytokines measured after PBMC stimulations, while one locus on chromosome 19 came from the whole-blood stimulation system (Table 1) . We identified cQTLs for both monocyte-and T cellderived cytokines upon bacterial and fungal stimulations, whereas stimulation with purified TLR ligands only yielded cQTLs for monocyte-derived cytokines ( Figure S3B ). The validity of the 17 loci was further corroborated for the 12 cytokine-microbial stimulations that were performed in the 200FG cohort. Of the cQTLs, 9/12 (75%) were replicated (p < 0.05), and, in all cases, the effects were in the same direction (Table S2 ). We could not replicate five of the cQTLs, as these stimulus-cytokine measurements were not tested in the 200FG cohort. No genome-wide significant cQTLs were identified for the macrophage production of cytokines, which agrees with the conclusion that the process of in vitro differentiation erases many of the differences between individuals. This conclusion has important consequences, as it suggests that in-vitro-differentiated cell systems (such as monocyte-derived macrophages or dendritic cells) may not be suitable for studying the genetics of cytokine responses.
Prioritizing cQTL-Affected Genes Indicates Those Involved in Microbial Sensing and Processing Molecules as Putative Causal Genes We used three approaches to identify the causal genes at the 17 significant cQTL loci. First, we tested whether the cQTLs were strongly correlated with other SNPs that alter the protein structure of any genes. Using the HaploReg SNP annotation tool Table S1 . (Ward and Kellis, 2012) , we extracted all SNPs in linkage disequilibrium (LD) (R 2 > 0.8; using the CEU population as a reference) with the cQTLs. We found two loci that were in strong LD with missense variants (Table S3) : SNPs rs28393318 and rs6834581 on chromosome 4 were in strong LD (R 2 = 0.97, D prime = 0.99) with a missense variant, rs4833095, on the TLR1 gene. SNP rs7256586 on chromosome 19 was in strong LD with a missense variant rs198977 (R 2 = 0.82, D prime = 0.92) on the KLK2 gene. These observations suggest that TLR1 and KLK2 could be causal genes at these cQTL loci. The À23 . Red indicates the minor allele associated with higher levels of cytokines, while blue indicates the minor allele associated with lower levels of cytokines. The x axis shows all 17 genome-wide significant loci, and the y axis shows the cytokine-stimuli pairs. WB, whole blood. See also Figure S3 and Tables S2 and S3. other 15 cQTLs and their proxies are all located in non-coding regions of the genome, suggesting a possible regulatory function of cQTL loci. As a second approach, we performed cis-eQTL mapping using RNA-sequencing (RNA-seq) data and genotype data from 629 healthy-donor blood samples (LifeLines-Deep cohort) (Ricañ o-Ponce et al., 2016; Tigchelaar et al., 2015) as well as eQTL results obtained from publicly available datasets provided by HaploReg (Ward and Kellis, 2012) .
As a third approach, we hypothesized that the genes that are differentially regulated in response to different microbial stimuli are the potential causal genes at our cQTL loci. To test this, we extracted all the genes, including the non-coding genes, located in a 500-kb cis-window of the 17 cQTLs and tested their expression in PBMCs stimulated with different microbial antigens (Figure S3C) . By combining these three approaches, we identified 21 putative causal genes in 12 of the loci (Table 1 ). In the remaining five loci, the gene nearest to the cQTL SNP is shown. Intriguingly, the genes we identified by these three approaches were all regulatory genes modulating cytokine production, rather than eQTLs directly modulating the transcription of cytokine genes and the production of cytokines themselves. The identified genes were mainly involved in microbial sensing (TLR1, TLR6, TLR10, CSMD1, CD63, CR2, and CD55), processing molecules (SLC36A4 and SLC37A2), endoplasmic reticulum organization, and cytokine signaling (IL1F10, IL1RN, and STAM2).
TLR1-TLR6-TLR10 Locus Is Associated with Cytokine Production Capacity for Diverse Stimulations
The strongest association among the 17 cQTL loci was at the TLR1-TLR6-TLR10 locus ( Figures 5A and 5B) on chromosome 4, influencing poly(I:C)-induced IL-6 (p = 3.93 3 10
À25
) and IL1b levels (p = 2.47 3 10 À10 ) in PBMCs. This locus also showed significant association with Coxiella burnetii-induced IL-1b (p = 4.62 3 10 À13 ) and TNF-a (p = 7.59 3 10 À8 ) levels, as well as moderate association with 20 different cytokine levels (false-discovery-rate [FDR]-corrected p < 0.05) in response to multiple other microbial stimulations ( Figure 4B ). This locus was also found to be under strong evolutionary selection (discussed later). Since we also had full transcriptomics data obtained by RNA-seq on PBMCs from 70 healthy individuals in the Lifelines-Deep cohort (Tigchelaar et al., 2015) stimulated with Candida albicans, we were able to construct co-expression networks for the various alleles of the TLR1-TLR6-TLR10 locus. Our pathway analysis showed an interesting differential induction of genes that are important for cytokine regulation and dependent on the cytokine-inducing allele (rs6834581*C) or the alternative allele (rs6834581*T) ( Figure S4 ). Many of these differentially regulated genes have been shown to be important for cytokine regulation; for example, TREML4 encodes for a protein crucial for TLR7 signaling and antiviral defense (Ramirez-Ortiz et al., 2015) , and SCGB3A1 encodes for the cytokine-like secretoglobin family 3A member 1 (or HIN-1), which plays an important role in lung inflammation (Yamada et al., 2009 ).
IL1F10-IL1RN Locus Is a Shared QTL for Cryptococcusand Influenza-Induced Cytokines
We found a significant cQTL for TNF-a levels in response to Cryptococcus (Figures 5C and 5D) on chromosome 2 (p = 4.22 3 10 À9 ). The same SNP (rs4496335) also has an effect on the expression of genes in the IL-1F10-IL1RN locus that encodes the IL-1 receptor antagonist. This locus also showed moderate association with IL-6 (3.38 3 10 À6 ) and IL-1b levels (5.51 3 10 À6 ) in response to Cryptococcus. IL-1Ra is a known natural antagonist of the IL-1 receptor pathway, but it was not known whether this also influences Cryptococcus-induced cytokine production. In order to validate this finding, we performed a series of experiments in which we show that pre-incubation of PBMCs with IL-1Ra significantly inhibits the induction of cytokines by Cryptococcus ( Figure S5A ). This is the only locus in our 17 cQTL loci that was also moderately associated with influenza-induced TNF-a, IL-1b, and IL-6 levels ( Figure 4A ). Unsupervised clustering analysis of cytokines ( Figure 2A ) showed much stronger similarities between influenza-and Cryptococcus-induced responses than between Cryptococcus and other fungi-induced responses, suggesting that these two pathogens activate similar inflammatory pathways. This association warrants further study.
CSMD1 and SLC36A4 Loci Specifically Regulate T Cell-Derived Cytokines
We quantified three T cell-derived cytokines (IL-22, IL-17, and interferon [IFN]-g) after stimulating PBMCs for 7 days with various stimuli. We found three genome-wide significant loci for IFN-g and two for IL-22 levels ( Table 1 ). The strongest association in these five loci was at the SLC36A4 locus on chromosome 11 (Figures S5B and S5C) , with Staphylococcus aureus-induced IL-22 levels (p = 2.42 3 10 À9 ). SLC36A4 encodes for an amino-acid transporter with a high affinity for glutamine, tryptophan, and proline (Pillai and Meredith, 2011) . Amino-acid metabolism (especially tryptophan and glutamine) has been reported to modulate cytokine production (Bosco et al., 2000; Coë ffier et al., 2001; Harden et al., 2015) . We validated this pathway in our study by showing that blocking glutaminolysis with BPTES (bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide) significantly inhibits S. aureusinduced IL-22 production ( Figure S5D ). The other cQTL for C. albicans-induced IL-22 levels was found on chromosome 8 (p = 2.42 3 10 À9 ) on the CSMD1 gene. CSMD1 encodes a protein that functions as a complement inhibitor (Escudero-Esparza et al., 2013) , and recent studies have shown that IL-22 and the complement pathway influence each other and synergize during host defense against pathogens (Yamamoto and Kemper, 2014) . The importance of the complement pathway for modulating cytokine production is underscored by the presence of CR2 and CD55 among the genes whose genetic variation regulates cytokine production (Table 1 ). Finally, we tested whether the five independent T cell cytokine QTLs were also associated with other cytokines. Although they were moderately associated with cytokines produced in response to other types of stimuli (e.g., Mycobacterium tuberculosis, Cryptococcus; see Table 1 ), CSMD1 and SLC36A4 loci were specifically associated with IL-22 and IFN-g production capacity.
KLK2-KLK4 Locus Is Significantly Associated with IL-6 Levels in Whole-Blood Stimulation
We quantified IL-6, IL-1b, TNF-a, and IFN-g after stimulating whole blood for 48 hr with various stimuli. We identified one locus on chromosome 19 as significantly associated (p = 8.50 3 10 À9 )
with C. albicans-induced IL-6 levels. This locus encodes for kallicrein-related peptidases 2 and 4 (KLK2 and KLK4); the latter has been described as inducing IL-6 production through activation of protease-activated receptor 1 (PAR-1), a well-known immune-activated receptor (Wang et al., 2010) . This locus is also moderately associated with both monocyte-and T cellderived cytokines in response to multiple microbial stimulations ( Figure 4A ).
cQTLs Are Enriched for Regions under Positive Selection and Monocyte-Specific Enhancers and Are Associated with Complex Human Diseases
Some of the cQTL loci were common to several stimuli, but many were stimulus specific ( Figure 4B ). This finding supports the conclusion that the cytokine response is evolutionarily built around the response to specific pathogens, a process most likely shaped by the selective evolutionary processes exerted by local infections in certain geographical locations. This is also supported by our observation that the cQTL genes are under strong selective pressure. We intersected our 17 cQTLs with the regions in the human genome catalogued as ''loci under positive selection'' in 230 ancient Eurasian genomes (Mathieson et al., 2015) . Our cQTLs were significantly enriched (Kolmogorov-Smirnov test, p value < 0.01) for ''genes under positive selection'' in the Eurasian genomes ( Figure 6A ), including the well-known TLR1-TLR6-TLR10 and LCT loci. The fact that the majority of the cQTL loci were in LD with SNPs in non-coding regions means that they could have regulatory functions. Therefore, we intersected these 17 top cQTLs and their proxies (r 2 % 0.8) with the ENCODE-defined cell-typespecific enhancers. This showed a significant enrichment of these cQTLs in monocyte-specific enhancers ( Figure 6B ), suggesting that many of the cQTLs influence gene expression in monocytes and, thereby, alter cytokine production. We also tested whether the 17 cQTLs are associated with human diseases. We intersected the cQTLs with GWAS SNPs known to influence susceptibility to various immune-mediated diseases. Interestingly, SNPs that affect monocyte-derived cytokines are also enriched for SNPs associated with infectious diseases (Figure 6C ). In contrast, cQTLs that affect T cell-derived cytokines are enriched for SNPs associated with autoimmune diseases ( Figure 6D ). In addition, we identified a trend for the association of cQTLs with SNPs associated with other complex human phenotypes, such as blood-related traits and cancer ( Figure 6E ). These results suggest that proinflammatory cytokines have an important role as underlying mediators in many complex human diseases.
DISCUSSION
In three complementary studies in this issue of Cell, we report on the impact of genetic (the present study), environmental (ter Horst et al., 2016) , and microbiome factors on the cytokine production capacity in a large cohort of healthy individuals of Western European background. The present study is broad both at the genomic level (8 million SNPs) and at a functional level: we assessed three types of cellular stimulation models (whole blood, PBMCs, and monocyte-derived macrophages) challenged with a comprehensive panel of bacterial, fungal, viral, and non-microbial metabolic stimuli. The data presented here support the hypothesis that genetic variation is one of the main factors influencing cytokine responses, with variation of several cytokines, especially the IL-1b/IL-6 pathway, being mainly regulated by genetic factors (Figures S6 and S7 ). In line with this, we identify 17 new genome-wide significant loci that influence cytokine production, and we provide genetic and functional validation for their biological importance. The conclusion that there is a high genetic heritability of cytokine production capacity in the context of microbial stimulation is supported by a recent study showing a strong genetic component in the regulation of multiple immune traits in twins (Roederer et al., 2015) . The genes we identify as cytokine regulators can be grouped into two processes: (a) innate immune genes, such as the pattern recognition receptors (e.g., the TLR1/6/10 cluster), and complement modulators; and (b) genes important for antigen processing in the endoplasmic reticulum. Among this last groups of genes, one of them (SLC36A4) is also an amino acid transporter, particularly for tryptophan, proline, and glutamine The identification of cell-type-dependent cQTLs and their potential relevance for infectious and autoimmune diseases in humans is of considerable interest. Our results imply that monocyte-derived cQTLs are associated to a susceptibility to infections, while T cell-derived cQTLs overlap with loci associated to autoimmune diseases. This result has important implications, as it provides a model to gain insight into the mechanistic basis of disease associations in a cell-type-specific manner. This important finding is underpinned by another HFGP study by Aguirre-Gamboa et al. (2016) , which describes cell-count QTLs that influence lymphocyte numbers being associated with susceptibility to autoimmune diseases. We were also able to further dissect the impact of the various cQTLs for different pathologies and have, for example, gained important new insight into the preferential impact of monocyte-derived cQTLs for blood-related (hematological) diseases, while these are seen to be less strongly involved in autoimmune diseases or cancer.
We also extracted additional important biological properties characterizing cytokine responses. First, we observed a surprisingly small impact of cell numbers on cytokine production capacity, even in the case of whole-blood stimulation, with only a few exceptions showing a moderate impact. This conclusion is supported by the results of a previous study published by our group (Li et al., 2016) and demonstrates that the most important impact on cytokine secretion is determined by the intrinsic cellular characteristics. Second, we identified an important pattern in the architecture of cytokine responses: the production capacity of various monocyte-derived or lymphocyte-derived cytokines correlated strongly when cells were stimulated with a specific pathogen, whereas the correlation was poor when comparing bacterial stimuli with fungal and viral stimuli. This makes sense from an evolutionary point of view, as immune responses mainly need to have plasticity to respond to specific infectious pressures in any given geographic area (Netea et al., 2012) . This conclusion is supported by the enrichment of cQTL genes among the genes recently reported to be under selection in Eurasian populations (Mathieson et al., 2015) . Finally, nearly all the cQTLs described here are trans-QTLs, and they were significantly enriched in monocyte-specific enhancers. This suggests that many cQTLs influence the expression of target genes in monocytes to alter cytokine production indirectly.
There are also a number of limitations to the present study. It is possible that we may have underestimated the heritability of cytokine responses by performing a SNP-based analysis. To address this aspect, it will be interesting in the future to assess the heritability of cytokine responses using longitudinal data, as this will allow us to take other factors (e.g., seasonal variation) into account. Moreover, future twin-based studies could take the stimulation aspect into account when performing the heritability estimation of immune parameters. In addition, although this is the most comprehensive study on cytokine production in humans so far, the number of cytokines measured is still relatively limited. We have chosen to study the most important proinflammatory cytokines produced by monocytes, Th1 and Th17 cells; however, future studies should also include other classes of cytokines, such as anti-inflammatory cytokines, IFNs, or chemokines.
In conclusion, we present a comprehensive analysis of how genetic variation affects cytokine production capacity in humans. Our study should be considered in the broader framework of the HFGP, in which environmental, non-genetic host factors and the microbiome have also been shown to influence immune responses (see the accompanying studies by ter Horst et al., 2016, and Schirmer et al., 2016, in this issue) . In a first study, we show that age is an important factor, with a specific defect of IFN-g and IL-22 production in the elderly (ter Horst et al., 2016) : future studies in a population of elderly individuals should assess whether the genetic factors identified here also play a role in this process. Similarly, gender and seasonality also influence immune responses. In addition, the accompanying study by Schirmer et al. demonstrates the impact of microbiome variability on cytokine responses. Although it is important to note that the microbiome has an important role, it does seem to have a smaller impact on cytokine production than host genetic factors: while we observe here a 25% to 75% genetic heritability for most of the cytokines mentioned, the microbiome variation explains up to 10% of the cytokine production capacity .
However, the genomic variation may act either directly or indirectly through impacting on other factors, e.g., the microbiome. In this respect, recent studies have reported host genetic factors that influence the microbiome Davenport et al., 2015; Goodrich et al., 2016; Knights et al., 2014) : future studies in the HFGP plan to integrate the complex patient-related and omics databases into comprehensive models to explain cytokine production and other complex immune traits. These complementary studies will be important in understanding the influences on human cytokine responses and their variation and can be used to pinpoint factors that can be modified and targeted for the personalized treatment of immune-mediated diseases. Finally, the HFGP in general, and these three studies reported in this issue of Cell in particular, offer an important methodology beyond the analyses of cytokine responses, because they provide a framework for future functional genomics studies looking to assess immune and non-immune biological processes.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: CONTACT FOR REAGENT AND RESOURCE SHARING Request should be directed and will be fulfilled by lead author Y.L. (y.li01@umcg.nl).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Ethics statement
The HFGP study was approved by the Ethical Committee of Radboud University Nijmegen, the Netherlands (no. 42561.091.12). Experiments were conducted according to the principles expressed in the Declaration of Helsinki. Samples of venous blood were drawn after informed consent was obtained.
Population cohorts
The study was performed in two independent cohorts of $500 and $200 healthy individuals of Western European ancestry from the Human Functional Genomics Project (500FG and 200FG cohorts, see www.humanfunctionalgenomics.org). The 500FG cohort comprises 534 adults from Nijmegen, the Netherlands (237 males and 296 females, age range 18-75 years). The 200FG cohort comprises Individuals from the 'Geldersch Landschap', 'Hoge Veluwe', 'Twickel', and 'Kroondomein het Loo' in the Netherlands (77% males and 23% females, age range 23-73 years old).
Stimuli
Bacteria
Bacteroides fragilis (NCTC 10584) grown anaerobically overnight at 37 C on blood agar plates (BD Biosciences, Franklin Lakes) was inoculated in 20 mL pre-warmed and pre-reduced Brain Heart Infusion broth (BD Diagnostics, Basel) and again grown anaerobically overnight at 37 C until reaching a stationary growth phase mimicking growth conditions in abscesses. Bacterial suspensions were washed three times in phosphate-buffered saline (PBS; B. Braun Medical B.V., Melsungen) and heat-killed at 95 C for 30 min. Before heat-killing, aliquots of bacterial suspensions were taken to determine colony-forming unit (CFU) counts. Heat-killed bacteria were washed again and after adjusting the concentration in PBS to 1 3 10 8 CFU/mL, stored at -80 C. B. fragilis was used in the stimulation experiments as 1 3 10 6 /mL.
E. coli ATCC 25922 was grown overnight in culture medium, washed three times with PBS, and heat-killed for 60 min at 80 C. Staphylococcus aureus strain ATCC 29213 was grown overnight in culture medium, washed twice with cold PBS, and heat-killed for 30 min at 100 C; both E. coli and S. aureus were used in a final concentration of 1 3 10 6 /mL. Success of heat-inactivation was confirmed by cultures. LPS (E. coli serotype 055:B5), a TLR4 ligand, was purchased from Sigma-Aldrich (St. Louis) and an extra purification step was performed as described previously (Hirschfeld et al., 2000) . Purified LPS was tested in TLR4 À/À mice for the presence of contaminants and did not show any TLR4-independent activity. CpG (ODN M362) was purchased from InvivoGen (San Diego) and used at a final concentration of 10 mg/mL. Cultures of H37Rv Mycobacterium tuberculosis (MTB) were grown to mid-log phase in Middlebrook 7H9 liquid medium (Difco, Becton Dickinson, East-Rutherford) supplemented with oleic acid/albumin/dextrose/catalase (OADC) (BBL, Becton Dickinson), washed three times in sterile saline solution, heat-killed and then disrupted using a bead beater, after which the concentration was measured using a bicinchoninic acid (BCA) assay (Pierce, Thermo Scientific, Rockville).
C. burnetii Nine Mile RSA493 (NM) phase I (a gift from the Bundeswehr Institute for Microbiology, Munich, Germany) was cultured on buffalo green monkey cells, and the numbers of Coxiella DNA copies were determined using TaqMan real-time polymerase chain reaction as described (Roest et al., 2012) . Lipopolysaccharide (LPS) phase determination was performed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and silver staining, using purified phase I (RSA493) and phase II (RSA439) C. burnetii NM LPS (kindly provided by R. Toman) as controls (Hitchcock and Brown, 1983; Schramek and Galanos, 1981) . C. burnetii was inactivated by heating for 30 min at 99 C. B. burgdorferi, ATCC strain 35210, was cultured at 33 C in Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% rabbit serum. Spirochetes were grown to late-logarithmic phase and examined for motility by dark-field microscopy. Organisms were counted using a Petroff-Hauser counting chamber. Bacteria were harvested by centrifugation of the culture at 3000 g for 30 min, washed twice with sterile PBS (pH 7.4), and diluted in the specified medium to the required concentrations of 1 3 10 6 spirochetes per mL. The serum-resistant Salmonella typhimurium strain (phage type 510) was grown at 37 C for 12 hr in nutrient broth (BHI Oxoid, Nepean). Bacteria were collected and centrifuged and then washed three times in PBS. Aliquots were stored at -20 C throughout the study. Fungi Heat-killed C. albicans blastoconidia (strain ATCC MYA-3573, UC 820) in a concentration of 10 6 CFU/mL were used throughout this study. A clinical isolate of Aspergillus fumigatus V05-27 was used for stimulations. Isolates were grown on YAG agar plates for 3 days at 37 C. Fungal spores in the presence of sterile 0.1% Tween 20 in PBS were harvested by gentle shaking, washed twice with PBS, filtered through a 40-mm pore size cell strainer (Falcon, Vienna) to separate conidia from contaminating mycelium. They were then counted by a hemacytometer, suspended at a concentration of 10 8 spores/mL and heat-killed. A final concentration of 1 3 10 7 /mL was used in the experiments. A clinical isolate of Cryptococcus gattii (A1M-R265, AFLP type 6) was freshly grown on Sabouraud dextrose agar plates. Afterward a suspension in PBS was heat-killed at 56 C for 24 hr and then quantified at a wavelength of 530 nm on a spectrophotometer. Killing efficiency as well as bacterial and fungal contamination was checked using Sabouraud dextrose and blood agar plates, respectively. Aliquots were stored at -20 C throughout the study.
Influenza virus culture and inactivation. Influenza virus strain pH1N1 A/Netherlands/602/09 (kindly provided by Prof. Ron Fouchier, Erasmus MC, Rotterdam) was grown in the allantoic fluid of embryonated chicken eggs. Viral titers were determined by three independent plaque assays performed on Madin-Darby canine kidney (MDCK) cells. To inactivate the pH1N1 strain, b-propiolactone (BPL) (Acros Organics, Morris Plans) in citrate buffer (125 mM sodium citrate, 150 mM sodium chloride [pH 8.2]) was added to the pH1N1 virus to a final concentration of 0.1% and incubated for 24 hr at 4 C under continuous slow shaking. Inactivated virus was subsequently snap-frozen and stored at -80 C. Virus inactivation was confirmed by three passages in MDCKs where no virus could be detected by plaque assay following the third passage. TLR ligands and non-microbial stimuli Pam3Cys, a TLR1/2 ligand, was purchased at EMC microcollections (L-2000) and used in a final concentration of 10 mg/mL.
PolyI:C, a TLR3 ligand, was purchased from InvivoGen and used at a final concentration of 100 mg/mL. PHA was purchased from Sigma and used at a final concentration of 10 mg/mL. Palmitic acid was purchased from Sigma-Aldrich. Human albumin (Albuman) was purchased from Sanquin (Amsterdam). Stock palmitic acid was dissolved in 100% ethanol. Palmitic acid (C16.0) and human albumin were conjugated by warming to 37 C in a water bath before adding together in a 1:5 ratio. The mixture was sonicated for 20-25 min and kept at 37 C until use. The vehicle control for 50 mM C16.0 consisted of 0.025% albumin and 0.025% ethanol. MSU crystals were formed by dissolving 1.0 g of uric acid and 0.48 g sodium hydroxide in 400 mL of sterile water. The pH was adjusted to 7.2 and the solution was sterilized by heating it for 6 hr at 120 C. No LPS contamination was detected by Limulus amoebocyte lysate assay.
METHOD DETAILS PBMC collection and stimulation experiments
After obtaining informed consent, venous blood was drawn from the cubital vein of volunteers into 10 mL EDTA Monoject tubes (Medtronic, Dublin). The PBMC fraction was obtained by density centrifugation of EDTA blood diluted 1:1 in pyrogen-free saline over Ficoll-Paque (Pharmacia Biotech, Uppsala). Cells were washed twice in saline and suspended in medium (RPMI 1640) supplemented with gentamicin (10 mg/mL), L-glutamine (10 mM) and pyruvate (10 mM). Addition of antibiotics such as gentamycin is a standard method used to avoid contamination of cultures, and it does not influence the ability to induce cytokine production by PBMCs or macrophages (data not shown). The cells were counted in a Coulter counter (Beckman Coulter, Pasadena) and the number was adjusted to 5 3 10 6 cells/mL. A total of 5 3 10 5 PBMCs in a total volume of 200 mL per well were incubated at 37 C in round-bottom 96-well plates with the different stimuli, as indicated above. After 24 h (for early cytokines IL-1b, TNF-a, IL-6, IL-8, and IL-10), or 7 days of incubation (for IFN-g and IL-17), supernatants were collected and stored at -20 C until assayed. The stimulation periods were chosen based on extensive studies that showed that 24 hr stimulation was best suited for assessing monocyte-derived cytokines. When cells were cultured for 7 days, this was done in the presence of 10% human pooled serum.
For validation experiments, PBMCs were incubated with recombinant IL-1Ra (R&D Systems, Minneapolis) 10 mg/ml, 30 min before stimulation with C. neoformans. The cytokine production capacity in the absence or presence of IL-1Ra was measured in the supernatants as described above.
Macrophage differentiation and stimulation
We cultured > 5 3 10 5 monocytes in flat-bottom plates with 10% human serum at 37 C and 5%CO 2 for 6 days. After differentiation, the medium was removed and the differentiated macrophages were stimulated for 24 hr. Supernatants were collected and stored in -20 C until used for ELISA.
Whole-blood stimulation experiments 100 mL of heparin blood was added to a 48-well plate and then stimulated with 400 mL stimulus (final volume 500 ml) for 48 hr at 37 C and 5%CO 2 . Supernatants were collected and stored in -20 C until used for ELISA.
Cytokine measurements
Concentrations of human IL-1b, IL-6, IL-10, TNF-a, IL-17, or IFN-g were determined using specific commercial ELISA kits (PeliKine Compact, Amsterdam, or R&D Systems), in accordance with the manufacturer's instructions. Detection limits were 31 pg/mL (IL-6 (macrophages), 39 pg/mL (IL-1b and IFNg), 156 pg/mL (IL-6 (whole blood), IL-22) or 78 pg/mL (TNF-a and IL-17).
Cytokine clustering and variance analysis Raw cytokine levels were first log-transformed, and cytokine measurements showing little/no variation across individuals were filtered out for the follow-up analysis. We excluded 17 stimulation-cytokine measurements that did not pass our quality control. Unsupervised hierarchical clustering was performed using Spearman's correlation as the measure of similarity. We used Levene's test to check the equality of variance of cytokine levels before and after stimulation.
Genotyping, quality control and imputation DNA samples of 500 individuals were genotyped using the commercially available SNP chip, Illumina HumanOmniExpressExome-8 v1.0. The genotype calling was performed using Opticall 0.7.0 (Shah et al., 2012) using default settings. Samples with a call rate % 0.99 were excluded from the dataset, as were variants with a Hardy-Weinburg equilibrium (HWE) % 0.0001, call rate % 0.99 and minor allele frequency (MAF) % 0.001. We identified 17 ethnic outliers by merging multi-dimensional scaling plots of samples with 1000 Genomes data and these were excluded from further analysis ( Figure S7 ). This resulted in a dataset of 483 samples containing genotype information on 518,980 variants for further imputation. The strands and variant-identifiers were aligned to the reference Genome of the Netherlands (GoNL, Genome of the Netherlands Consortium, 2014) dataset using Genotype Harmonizer (Deelen et al., 2014a) . The data were phased using SHAPEIT2 v2 (Delaneau et al., 2013) using GoNL as a reference panel. Finally, these data were imputed using IMPUTE2 (Howie et al., 2011) with GoNL as the reference panel (Deelen et al., 2014b) . We selected SNPs that showed an INFO score R 0.8 upon imputation for further cytokine QTL mapping.
Cytokine QTL mapping
Both genotype and cytokine data could be generated for a total of 442 individuals. We obtained cell count data measured by FACS for total lymphocytes, T cells, B cells, monocytes and NK-cells from 487 individuals from the 500FG cohort. In total, there were 409 samples with genotype, cytokine, and cell-count data. We excluded 17 samples due to genetic differences. We coded gender information either 0 for females or 1 for males. The actual age, gender, and cell-count information were included as covariables in the linear model to correct the cytokine distributions for QTL mapping. Raw cytokine levels were first log-transformed then mapped to genotype data using a linear regression model with age and gender as covariates. Since the stimulation-cytokine combinations cannot be regarded as completely independent (we observed strong correlations in the cytokine clustering analysis we performed), the total number of independent tests among all phenotypes will be much less than the number of phenotypes measured, and therefore correcting for the number of SNPs tested for each trait should be sufficient. We considered a p value of < 5 3 10 À8 to be the threshold for significant cytokine QTLs.
Cytokine heritability estimation
Using the GCTA tool (Yang et al., 2010) , we fitted a linear mixed model to each of the 112 cytokine phenotypes and used restricted maximum likelihood to estimate the variance explained by the approximately 8 million SNPs. Following our method for cQTL mapping, we also included age, gender, and cell counts as covariates for estimating the proportions of phenotypic variance explained by the SNPs. It should be noted that the 95% confidence intervals for the heritability estimate are wide due to the sample size (N < 1000) in this study (Zaitlen and Kraft, 2012) .
Expression QTL analysis to prioritize causal genes RNA sequencing of 629 peripheral blood samples from the LifeLines-Deep cohort (Tigchelaar et al., 2015) were investigated to map cis-eQTLs. The eQTL mapping strategy and data have been described in detail (Ricañ o-Ponce et al., 2016) . Briefly, cis-eQTL analysis was performed on transcript-SNP combinations for which the distance from the center of the transcript to the genomic location of the SNP was % 500 kb. Associations were tested by non-parametric Spearman's rank correlation test and a p value < 0.05 was considered significant. We also employed HaploReg database v4.1 (Ward and Kellis, 2012) (www.broadinstitute.org/mammals/haploreg/ haploreg.php) to extract publicly available eQTL results from blood tissue for cytokine QTL SNPs.
Genotype-dependent gene expression analysis at rs6834581
The PBMCs from 70 individuals in the Lifelines-Deep cohort (Tigchelaar et al., 2015) were stimulated with or without Candida albicans as previously described (Smeekens et al., 2013; Kumar et al., 2014b) . The RNA sequencing analysis of this dataset has been described by previously (Li et al., 2016) . There were 7 CC, 25 CT and 38 TT individuals carrying these genotypes at rs6834581. We combined CC and CT in one group and compared the median expression-fold changes of genome-wide transcripts between two genotype groups (CC+CT versus TT). We focused on the absolute fold changes between these two groups and show the expression levels of the top 30 genes in Figure S4 .
Candidate genes located within a cis-window of approximately 500 kb of all significant cytokine QTL loci were further tested to see if they responded to any of the pathogens using RNA-seq data from PBMCs of eight individuals, which were stimulated by Pseudomonas aeruginosa, Streptococcus pneumoniae, Mycobacterium tuberculosis, Candida albicans, Aspergillus fumigatus, and IL-1a (Li et al., 2016) .
Intersection of ENCODE enhancers and regions under positive selection
To perform enhancer enrichment analysis on cytokine QTL SNPs, we extracted all proxies for the 17 cQTLs (R 2 R 0.8; CEU population as a reference) to have 186 variants. We then intersected these variants with enhancer data of 127 different cell lines available in HaploReg tool v4.1 (www.broadinstitute.org/mammals/haploreg/haploreg.php). HaploReg calculates a background frequency of enhancer overlap in each cell type using two background sets of SNPs. It compares the data with all independent GWAS loci associated in the European population, and with a second set of background SNPs consisting of all 1000 Genomes variants with a frequency > 5%. Initial enrichment of enhancers is calculated using the Binomial test and we applied the Bonferroni correction for multiple testing to define significance levels (0.05/127 cell lines).
Extraction of infectious disease associated SNPs
SNPs associated with a number of infectious diseases that showed a p value < 9.99 3 10 À6 were extracted using the GWAS catalog (http://www.genome.gov/gwasstudies). As of December 2014, there were two studies on leprosy, two studies on malaria, four studies on tuberculosis, four studies on chronic hepatitis C infection, one study on HPV seropositivity, one study on Dengue shock syndrome, and one study on meningococcal susceptibility. From a systematic search of the literature, we extracted SNPs associated with susceptibility to other infectious diseases but not reported in the GWAS catalog. We found three studies on invasive aspergillosis and two studies on pneumococcal disease (see the list published in Li et al. (2016) .
GWAS SNP extraction and enrichment analysis GWAS SNPs from the GWAS catalog and their proxies (r 2 R 0.8 from a 500 kb window) were first extracted, which provided a list of SNPs associated to 122 different human traits and diseases. We selected diseases/traits for which at least 10 independent SNPs were reported to be associated. We then binned these GWAS SNPs into eight categories based on their association to closely related human phenotypes (cancer, immune-mediated diseases, infectious disease, heart-related traits, blood-related traits, metabolic traits, height, and Type 2 diabetes-related traits). Duplicated SNPs were removed from further analysis. We then intersected the SNPs of each category with cQTLs that showed p < 0.05 in our study. The Fisher exact test was applied to test the over-representation of cQTL SNPs in infectious disease SNPs using the height-associated SNPs as reference.
Enrichment for positive selection
The cytokine QTLs at different thresholds (1 3 10 À7 , 1 3 10 À6 , 1 3 10
À5
, 1 3 10 À4 ) were intersected with loci under positive selection (Mathieson et al., 2015) . The distribution of positive selection p values on cQTL SNPs were compared with a randomly selected set of non-significant cQTL SNPs (p > 0.01) by using Kolmogorov-Smirnov test.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed in R. Unsupervised hierarchical clustering was performed using Spearman's correlation as the measure of similarity. The Levene's test to check the equality of variance of cytokine levels before and after stimulation. R-package Matrix-eQTL, was used for cytokine QTL mapping, where linear model was applied with age, gender, and cell-count information included as covariables. The Fisher exact test was applied to test the over-representation of cQTL SNPs in infectious disease SNPs using the height-associated SNPs as reference.
DATA AND SOFTWARE AVAILABILITY
Online database All data used in this project have been meticulously cataloged and archived in the BBMRI-NL data infrastructure (https://hfgp. bbmri.nl/) using the MOLGENIS open source platform for scientific data (Swertz et al., 2010) . This allows flexible data querying and download, including sufficiently rich metadata and interfaces for machine processing (R statistics, REST API) and using FAIR principles to optimize Findability, Accessibility, Interoperability and Reusability (Wilkinson et al., 2016) .
